Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Life science investment trust Syncona said it had completed the sale of its portfolio company Blue Earth Diagnostics to Bracco Imaging for $476.3m (£390.2m).
The sale of Blue Earth would generate £336.9m of net proceeds for Syncona for its 89% stake in the business.
This would further strengthen its strategic capital pool which underpinned the execution of its strategy of founding, building and funding global leaders in life science, the company said.
At 9:38am: (LON:SYNC) Syncona Ltd share price was +3p at 257p